CD14+ CD16+ monocytes rather than CD14+ CD51/61+ monocytes are a potential cytological marker of circulating osteoclast precursors in multiple myeloma. A preliminary study.
Petitprez V et al. Int J Lab Hematol. 2014 Mar 24. doi: 10.1111/ijlh.12216. [Epub ahead of print].

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma.
Martinez-Lopez J et al. Blood. 2014 Mar 19. [Epub ahead of print].

Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma.
Kastritis E et al. Leukemia. 2014 Mar 18. doi: 10.1038/leu.2014.110. [Epub ahead of print].

Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma.
Rueff J et al. Biol Blood Marrow Transplant. 2014 Mar 13. pii: S1083-8791(14)00156-6. doi: 10.1016/j.bbmt.2014.03.007. [Epub ahead of print].

Plasma cell myeloma with unusual morphology-A series of 6 cases.
Gupta R et al. Eur J Haematol. 2014 Mar 14. doi: 10.1111/ejh.12310. [Epub ahead of print].

Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation.
Song MK et al. Br J Haematol. 2014 Mar 15. doi: 10.1111/bjh.12820. [Epub ahead of print].

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.
Gonsalves WI et al. Leukemia. 2014 Mar 12. doi: 10.1038/leu.2014.98. [Epub ahead of print].

Multiple myeloma and diagnostic imaging.
Reisenbuckler C. Radiol Technol. 2014 Mar-Apr;85(4):391-410.

Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents.
Kuroda J et al. Int J Hematol. 2014 Mar 1. [Epub ahead of print].

Monitoring M-Proteins in Patients with Multiple Myeloma Using Heavy-Chain Variable Region Clonotypic Peptides and LC-MS/MS.
Barnidge DR et al. J Proteome Res. 2014 Mar 5. [Epub ahead of print].

Ferritin as prognostic marker in multiple myeloma patients undergoing autologous transplantation.
Strasser-Weippl K et al. Leuk Lymphoma. 2014 Mar 18. [Epub ahead of print].